Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:31 AM
Study NCT ID:
NCT06284902
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2024-02-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioavailability Study of Fexofenadine HCl New Formulation Tablet
Sponsor:
Opella Healthcare Group SAS, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-23
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-22
First Submit QC Date:
None
Study First Post Date:
2024-02-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-08
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED